For PD-L1 CPS, there was no significant difference in DCR between patients with PD-L1 CPS ≥ 1 tumor vs. those with PD-L1 CPS < 1 tumor (7/13 [53.8%] vs. 4/16 [25.0%], P = 0.142; Fig. 2f). The gene discussed is CD274; the disease is neoplasm.